{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:13Z","timestamp":1792787293302,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NCI","award":["P30 CA006973"],"award-info":[{"award-number":["P30 CA006973"]}]},{"name":"NIH\/NCI","award":["P50 CA228991"],"award-info":[{"award-number":["P50 CA228991"]}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1136\/ijgc-2024-005920","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:50:55Z","timestamp":1729039855000},"page":"1737-1744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association of glutaminase expression with immune-suppressive tumor microenvironment, clinicopathologic features, and clinical outcomes in endometrial cancer"],"prefix":"10.1016","volume":"34","author":[{"given":"Shiho","family":"Asaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7301-1817","authenticated-orcid":false,"given":"Neha","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Tai","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiro","family":"Nonogaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-An","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Asaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo M","family":"DeMarzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ie-Ming","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2024-005920_bb0010","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2024-005920_bb0015","unstructured":"National Cancer Institute . Surveillance, epidemiology, and end results (seer) program cancer stat facts: uterine cancer. Available: https:\/\/seer.cancer.gov\/statfacts\/html\/corp.html [Accessed 8 Oct 2024]."},{"key":"10.1136\/ijgc-2024-005920_bb0020","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1136\/ijgc-2024-005920_bb0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-bioeng-071516-044546","article-title":"Glutaminolysis: A Hallmark of Cancer Metabolism","volume":"19","author":"Yang","year":"2017","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1136\/ijgc-2024-005920_bb0030","doi-asserted-by":"crossref","first-page":"589508","DOI":"10.3389\/fonc.2020.589508","article-title":"Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"key":"10.1136\/ijgc-2024-005920_bb0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fcell.2017.00038","article-title":"MYC and AMPK-Save Energy or Die!","volume":"5","author":"Haikala","year":"2017","journal-title":"Front Cell Dev Biol"},{"key":"10.1136\/ijgc-2024-005920_bb0040","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1158\/0008-5472.CAN-19-3971","article-title":"Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers","volume":"80","author":"Shen","year":"2020","journal-title":"Cancer Res"},{"key":"10.1136\/ijgc-2024-005920_bb0045","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"key":"10.1136\/ijgc-2024-005920_bb0050","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4049\/jimmunol.0903586","article-title":"Glutamine uptake and metabolism are coordinately regulated by ERK\/MAPK during T lymphocyte activation","volume":"185","author":"Carr","year":"2010","journal-title":"J Immunol"},{"key":"10.1136\/ijgc-2024-005920_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00353","article-title":"Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy","volume":"9","author":"Kouidhi","year":"2018","journal-title":"Front Immunol"},{"key":"10.1136\/ijgc-2024-005920_bb0060","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Science"},{"key":"10.1136\/ijgc-2024-005920_bb0065","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1158\/1535-7163.MCT-20-0430","article-title":"The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell-Mediated Immunotherapies","volume":"20","author":"Varghese","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"10.1136\/ijgc-2024-005920_bb0070","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 Blockade in Tumors with Mismatch-Repair Deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2024-005920_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.19.02105","article-title":"Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability\/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study","volume":"38","author":"Marabelle","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2024-005920_bb0080","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1200\/JCO.21.01874","article-title":"Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study","volume":"40","author":"O\u2019Malley","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2024-005920_bb0085","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1001\/jamaoncol.2020.4515","article-title":"Clinical Activity and Safety of the Anti-Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair-Deficient Endometrial Cancer: A Nonrandomized Phase 1 Clinical Trial","volume":"6","author":"Oaknin","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1136\/ijgc-2024-005920_bb0090","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S1470-2045(19)30020-8","article-title":"Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial","volume":"20","author":"Makker","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2024-005920_bb0095","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1200\/JCO.19.02627","article-title":"Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer","volume":"38","author":"Makker","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2024-005920_bb0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1056\/NEJMoa2108330","article-title":"Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer","volume":"386","author":"Makker","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2024-005920_bb0105","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa2302312","article-title":"Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer","volume":"388","author":"Eskander","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2024-005920_bb0110","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1056\/NEJMoa2216334","article-title":"Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer","volume":"388","author":"Mirza","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2024-005920_bb0115","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/modpathol.2008.111","article-title":"Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis","volume":"21","author":"Gurel","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1136\/ijgc-2024-005920_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13163963","article-title":"The Biological and Clinical Significance of Glutaminase in Luminal Breast Cancer","volume":"13","author":"Masisi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1136\/ijgc-2024-005920_bb0125","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"10.1136\/ijgc-2024-005920_bb0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-019-0412-9","article-title":"Estrogen inhibits autophagy and promotes growth of endometrial cancer by promoting glutamine metabolism","volume":"17","author":"Zhou","year":"2019","journal-title":"Cell Commun Signal"},{"key":"10.1136\/ijgc-2024-005920_bb0135","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/1871520622666220513163341","article-title":"The Glutaminase Inhibitor Compound 968 Exhibits Potent In vitro and In vivo Anti-tumor Effects in Endometrial Cancer","volume":"23","author":"Guo","year":"2023","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1136\/ijgc-2024-005920_bb0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1074-7613(03)00359-5","article-title":"Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy","volume":"20","author":"Wang","year":"2004","journal-title":"Immunity"},{"key":"10.1136\/ijgc-2024-005920_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2013.12.005","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Nishikawa","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1136\/ijgc-2024-005920_bb0150","doi-asserted-by":"crossref","first-page":"R246","DOI":"10.1016\/j.cub.2020.01.031","article-title":"Tumor-associated macrophages","volume":"30","author":"Cassetta","year":"2020","journal-title":"Curr Biol"},{"key":"10.1136\/ijgc-2024-005920_bb0155","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.it.2019.02.003","article-title":"Targeting Tumor-Associated Macrophages in Cancer","volume":"40","author":"Pathria","year":"2019","journal-title":"Trends Immunol"},{"key":"10.1136\/ijgc-2024-005920_bb0160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.molmed.2014.10.009","article-title":"Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway","volume":"21","author":"Ohaegbulam","year":"2015","journal-title":"Trends Mol Med"},{"key":"10.1136\/ijgc-2024-005920_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/genes12091305","article-title":"Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics Analysis","volume":"12","author":"Zou","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1136\/ijgc-2024-005920_bb0170","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41379-018-0172-x","article-title":"T cell-inflamed phenotype and increased Foxp3 expression in infiltrating T-cells of mismatch-repair deficient endometrial cancers","volume":"32","author":"Asaka","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1136\/ijgc-2024-005920_bb0175","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1007\/s12094-021-02645-2","article-title":"Targeting GLS1 to cancer therapy through glutamine metabolism","volume":"23","author":"Yu","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"10.1136\/ijgc-2024-005920_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/biom11121749","article-title":"A Combination of Glutaminase Inhibitor 968 and PD-L1 Blockade Boosts the Immune Response against Ovarian Cancer","volume":"11","author":"Wang","year":"2021","journal-title":"Biomolecules"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25001355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25001355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2024-005920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T20:37:48Z","timestamp":1762029468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X25001355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1048891X25001355"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2024-005920","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of glutaminase expression with immune-suppressive tumor microenvironment, clinicopathologic features, and clinical outcomes in endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2024-005920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}